Objectives: The objectives of this study were to explore the median effective dose (ED50) and the dose required for successful anesthesia in 95% of the patients (ED95) of remimazolam for intravenous anesthesia in adult outpatients undergoing gastroscopy.
Methods: This pilot study was conducted in patients scheduled to undergo painless gastroscopy at the authors' hospital between March 15, 2022 and March 25, 2022. The ED of remimazolam was determined using the modified Dixon sequential method, using an initial induction dose of 0.2 mg/kg. With successful or failed anesthesia, the remimazolam dose was decreased or increased by 0.05 mg/kg for the next patient, respectively.
Results: Twenty-two patients (43.6 ± 10.5 years of age) were enrolled. During gastroscopy, the remimazolam induction dose was 19.93 ± 2.96 mg (0.2-0.45 mg/kg). Eighteen patients could complete anesthesia with remimazolam alone, and four patients needed propofol to complete anesthesia. The induction time after the injection of remimazolam was 20.8 ± 8.4 s, the gastroscopy time was 5.1 ± 1.3 min, and the anesthesia recovery time was 17.5 ± 5.6 min. The ED50 and the ED95 of remimazolam were 0.362 mg/kg (95% confidence interval [CI]: 0.313-0.455 mg/kg) and 0.464 mg/kg (95% CI: 0.403-2.242 mg/kg), respectively. The vital signs of all patients remained within the predefined acceptable limits. No patients required antagonist rescue.
Conclusion: The ED50 and ED95 of remimazolam for adult gastroscopy were 0.362 mg/kg and 0.464 mg/kg, respectively. Additional anesthetics might be required during gastroscopy in some patients.
Trial Registration: The trial was registered. The number is ChiCTR2200057446.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11001170 | PMC |
| http://dx.doi.org/10.4103/ijp.ijp_425_22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of remimazolam toluene sulfonate on the cognitive function of juveniles and its mechanism of action.
Eur J Med Res
November 2024
School of Anesthesiology, Zunyi Medical University, Zunyi, China.
Remimazolam is a new benzodiazepine. Currently, it remains unclear how repeated exposure to remimazolam affects the cognitive function of the developing brain. In the present study, the equivalent doses of the two sedatives were derived from S-shaped dose-response curves, and the ED95 of remimazolam was 45 mg/kg (95% CI 37.
View Article and Find Full Text PDFThe dose of remimazolam combined with sufentanil for the induction of general anesthesia in obese patients undergoing bariatric surgery: an up-and-down sequential allocation trial.
Front Pharmacol
September 2024
Department of Anesthesiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Article Synopsis
- Remimazolam is a new water-soluble benzodiazepine designed for quick sedation, and this study sought to find its optimal dosage for inducing general anesthesia in obese patients undergoing bariatric surgery.
- The study included 39 patients over several months, using the Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scale to measure sedation effectiveness, with initial doses of remimazolam and sufentanil based on lean body weight.
- Results revealed that the half-effective dose (ED) of remimazolam combined with sufentanil was approximately 0.115 mg/kg, with the time of loss of consciousness averaging around 120.13 seconds for successful sedation.
The Impact of Fentanyl on the Effective Dose of Remimazolam-Induced Sedation in Elderly Female Patients: An Up-and-Down Sequential Allocation Trial.
Drug Des Devel Ther
August 2024
Department of Anesthesiology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital, Hangzhou First People's Hospital Qianjiang New City Campus, Zhejiang Chinese Medical University), Hangzhou, People's Republic of China.
Purpose: This study aimed to investigate the influence of fentanyl on the effective dose of remimazolam-induced sedation in elderly female patients undergoing general anesthesia.
Patients And Methods: Sixty female patients aged 65-80 years undergoing selective general anesthesia were randomized into two groups: Group R+F received an initial dose of remimazolam (7.5 mg) with fentanyl (1 μg/kg), while Group R received remimazolam alone.
Exploring the ED50 and ED95 of Remimazolam for Laryngeal Mask Airway Insertion During General Anesthesia in Pediatric Strabismus Correction Surgery.
Ann Ital Chir
August 2024
Department of Anesthesiology, Ningbo No.2 Hospital, 315000 Ningbo, Zhejiang, China.
Article Synopsis
- The study investigated the effective doses (ED50 and ED95) of remimazolam for laryngeal mask airway insertion in pediatric patients undergoing strabismus correction surgery.
- It included 32 children aged 3-12 and employed a precise dosage method to determine the necessary amounts for effective sedation.
- Results showed that the ED50 was 0.300 mg/kg and ED95 was 0.369 mg/kg, with patients maintaining stable vital signs throughout the procedure, indicating safety and reliability for clinical use.
ED50 and ED95 of Remimazolam Tosilate Combined with Different Doses of Fentanyl in Elderly Patients for Painless Gastroscopy.
Drug Des Devel Ther
June 2024
Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.
Background: The novel short-acting benzodiazepine drug, remimazolam tosilate, has been employed for sedation during endoscopic procedures. The optimal loading dosage of remimazolam tosilate in gastroscopy for elderly patients when co-administered with fentanyl remains unclear. Therefore, the primary objective of our research was to ascertain the median effective dose (ED50) and the 95% effective dose (ED95) of remimazolam tosilate in combination with various fentanyl dosages for elderly patients undergoing painless gastroscopy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!